June 2016, Volume :116 Number 6 , page 23 - 23 [Buy]
Join NursingCenter to get uninterrupted access to this Article
* Brivaracetam (Briviact) is a new antiepileptic approved to treat partial-onset seizures.
* The most common adverse effects are somnolence and sedation, dizziness, fatigue, and nausea and vomiting.
Join NursingCenter on Social Media to find out the latest news and special offers
© 2024 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved. – Terms & Conditions – Privacy Policy – Disclaimer – Your California Privacy Choices -- v09.09.00